Researchers at Karolinska Institutet have made significant progress in the search for new treatments for Parkinson’s disease. By manipulating the gene expression of non-neuronal cells in the brain, they were able to produce new dopamine neurons. The study, performed on mice and human cells, is published in the prestigious scientific journal Nature Biotechnology.
Scientists from Tomsk Polytechnic University (TPU) and Siberian State Medical University (SSMU) develop a diagnosis system for neurodegenerative diseases at early stages. They are such diseases as multiple sclerosis, Parkinson’s disease and others. The diagnosis system is based on virtual reality technology – a person is immersed in a virtual environment to carry out some functional tests. Researchers change the parameters of the virtual environment and record changes in the person’s movements. The scientists are going to complete the technical part of the project in 2017.
Scientists at the Tomsk Polytechnic University (TPU) have partnered up with colleagues from the Tomsk-based Siberian State Medical University (SSMU) to develop an innovative system for early-stage diagnostics of neurodegenerative diseases, such as multiple sclerosis, Parkinson’s and others. At the core of the new diagnostics is virtual reality; a person is immersed in a virtual environment for physicians to conduct functional tests. Researchers model the VR environment as they deem fit, and then register changes in the way the testee moves. The team hopes to complete preparations for project launch next year.
For more than five years, urine and cerebral-spinal fluid samples from patients with Parkinson’s disease have been locked in freezers in the NINDS National Repository, stored with the expectation they might someday help unravel the still-hidden course of this slow-acting neurodegenerative disease.